| Mar 23, 2026 | Congruence Therapeutics | $39.5M Other Equity | DIMENSION, OrbiMed | Amplitude Ventures, BDC Capital, Driehaus Capital Management, Investissement Québec, Silver Arc Private Capital |
| Jan 7, 2026 | Nocion Therapeutics | $23.0M Series B Extension | Pini Orbach, Monograph Capital | Canaan Partners, F-Prime Capital, Mass General Brigham Ventures, Mission BioCapital, Morningside, Osage University Partners |
| Sep 4, 2025 | Congruence Therapeutics | $32.0M Other Equity | — | Alexandria Venture Investments, Nancy Harrison, BDC Capital, Driehaus Capital Management, Investissement Québec, Daniel Hétu, OrbiMed, Silver Arc Private Capital |
| Jan 1, 2025 | Sound Blade Medical | $17.0M Series A | Amzak Health, Lumira Ventures | Aperture Venture Partners |
| Aug 1, 2024 | HistoSonics | $100.0M Series D | Chris Dimitropoulos | Johnson & Johnson Innovation, Sonder Capital, Amzak Health, HealthQuest Capital, Johnson & Johnson Innovation, State of Wisconsin, State of Wisconsin Investment Board, Venture Investors, Yonjin Capital |
| Jan 30, 2024 | Cour Pharmaceuticals Development | $105.0M Series A | Alpha Wave Ventures, Benjamin Rovinski, Ph.D. | Angelini Ventures, Bristol Myers Squibb, JDRF, Pfizer, Simon Greenwood |
| Jan 1, 2024 | Cyrano Therapeutics | $9.0M Series B | Florida Opportunity Fund, Lumira Ventures, Remiges Ventures | DeepWork Capital |
| Nov 28, 2023 | AmacaThera | $2.9M Series A Extension | — | BDC Capital, Inveready, Lu Han 韩路 PhD, MaRS IAF, StandUp Ventures |
| Apr 1, 2023 | Antiva Biosciences | $53.0M Series E | Florencia Segal | Adjuvant Capital, Canaan Partners, Johnson & Johnson Innovation, Osage University Partners, Canaan Partners, Google Ventures, Sofinnova Ventures |
| Dec 14, 2022 | HistoSonics | $100.0M Debt / Other Equity | Johnson & Johnson Innovation | Signature Bank, State of Wisconsin Investment Board, Venture Investors, Yonjin Capital |
| Oct 1, 2022 | PIC Therapeutics | $35.0M Series A | Tal Zaks | Advent Life Sciences, Belinda Termeer, Advent Life Sciences, Harrington Discovery Institute, Gerry Brunk |
| Jun 13, 2022 | Corvia Medical | $54.0M Other Equity | — | Accelmed, Edwards Lifesciences, General Catalyst, Third Rock Ventures |
| Dec 1, 2021 | OncoMyx Therapeutics | $50.0M Series B | B Capital Group, Benjamin Rovinski, Ph.D. | Boehringer Ingelheim, City Hill Ventures, Delos Capital, Korea Investment Partners, LYZZ Capital, Madison Partners, Xeraya Capital |
| Nov 17, 2021 | Deka Biosciences | $20.0M Series A | Juergen Eckhardt, Benjamin Rovinski, Ph.D. | Alexandria Venture Investments, O-Bio |
| Nov 1, 2021 | Antiva Biosciences | $31.0M Series D | Adjuvant Capital | Canaan Partners, Johnson & Johnson Innovation, Osage University Partners, Alexandria Venture Investments, Avestria Ventures, Brace Pharma Capital, Canaan Partners, Dong-A ST, Gaingels, Google Ventures, HBM Healthcare Investments, Mana Ventures, Sirona Capital, Sofinnova Ventures |
| Nov 1, 2021 | Antios Therapeutics | $75.0M Series B | EPIQ Capital Group, Craig Gordon | Domain Associates, Pontifax Venture Capital, Adage Capital Management, Aisling Capital, Altium Capital, Amzak Health, Avego Bioscience Capital, CAM Capital, Delos Capital, Granite Point Capital, GRA Venture Fund, Heartland Healthcare Capital, LifeSci Venture Partners, RA Capital Management, Sixty Degree Capital, Soleus Capital |
| May 20, 2021 | Biotheryx | $92.0M Series E | Farallon Capital Management | Alexandria Venture Investments, Avidity Partners, Deep Track Capital, Irving Investors, Janus Henderson Investors, Point72, Rock Springs Capital, Surveyor Capital, Tekla Capital Management, Wedbush Healthcare Partners |
| Apr 1, 2021 | Antios Therapeutics | $96.0M Series B | Guy Levy | Domain Associates, Michele Park, Pontifax Venture Capital, Sanofi Ventures, Adage Capital Management, Aisling Capital, Amzak Health, CAM Capital, Delos Capital, Granite Point Capital, LifeSci Venture Partners, RA Capital Management, Sixty Degree Capital |
| Feb 16, 2021 | Iterion Therapeutics | $17.0M Series B | Benjamin Rovinski, Ph.D. | Green Park & Golf Ventures, Sante Ventures, Venture Investors |
| Feb 15, 2021 | Notch Therapeutics | $85.0M Series A | — | David Chang, Amplitude Ventures, Casdin Capital, CCRM Enterprises Holdings, EcoR1 Capital, Samsara BioCapital |
| Feb 1, 2021 | AmacaThera | $10.0M Series A | Peter van der Velden, MBA, M.Sc. | BDC Venture Capital, CR Capital Management, Inveready, MaRS IAF, MBX Capital, Mike Serrano-Wu, StandUp Ventures |
| Dec 10, 2020 | Cyrano Therapeutics | $12.8M Series A | Gerry Brunk, Takahide Koda | — |
| Jun 8, 2020 | HistoSonics | $40.0M Series C | Wen Chen | Johnson & Johnson Innovation, State of Wisconsin Investment Board, Varian Medical Systems, Venture Investors |
| Oct 3, 2019 | AmacaThera | $3.6M Seed | Viva Ventures Biotech Group | Grey Sky Venture Partners, Peter van der Velden, MBA, M.Sc. |
| Oct 1, 2019 | Endotronix | $70.0M Series D Extension | — | Aperture Venture Partners, BioVentures Investors, OSF Ventures, Seroba Life Sciences, Skydeck, SV Health Investors, Wanxiang Healthcare Investments |
